Good Laboratory Practices
Good
Laboratory Practices is the set of
principles that are performed for the assurance of the quality as well as the
integrity of the nonclinical laboratory studies. These studies are considered
as the marketing permits and also support research for new products. This is
most commonly connected with the pharmaceutical agencies and required for the
approval of the new drug products with the help of non-clinical animal testing.
However, GLP is also associated with many other agents (non- Pharmaceutical)
that include medical devices, food additives, food contamination limits, and
food packaging. These are the accepted
method to carry out different activities in the laboratory. According to all
the organizations and authorities, this is the way to ensure the safety related
to the research done for new products. These practices also show a positive
impact on the quality of the result.
When is GLP necessary and Unnecessary for Medical
Devices:
The
different type of studies of GLP for pharmaceuticals and bio pharmaceuticals are
clear, but GLP studies for the medical devices is not that clear or less
obvious. To make GLP more understandable it is important to consider intrinsic
safety. If the device is intrinsically safe for the humans then they can be
unsafe if you are using them unsterile on the human’s wound. An intrinsically unsafe device will be made
from the highly toxic material. No amount of sterilization will make that
device harmless to use in humans. With this understanding, we have three
classes of studies to discuss that when GLP should apply to those studies.
Biocompatibility Studies
Biocompatibility
studies are performed for the safety and to evaluate the effect of the device
on a biological system. Biocompatibility studies according to GLP are required
for PMA submissions. Biocompatibility studies performed to support 510(k)
submissions are done according to GLP also.
Validation Studies
This
study will validate the process that will be used to make the device free from
all the microorganisms to make them suitable for the use of humans. However,
these studies are not helping to know about the intrinsic safety of the medical
device. For this study GLP is not that necessary.
Chemical Characterization Studies
According
to the GLP regulations, there is no classification of the other studies available
as it is done for nonclinical laboratory studies. These other studies can be including
exploratory and physical or chemical properties determination studies. These
types of studies don’t require GLP to followed, but these studies need to
support PMA or 510(k) submission.
The
purpose of the Standard operating
procedure is for distributing task, roles, and responsibilities while
performing the clinical trials with a medical device. The medical device can be
anything that can be used for the purpose of monitoring, treatment, diagnosis,
investigation, and prevent any injury.
The Standard operating procedure will ensure that everything was done
according to the laws and regulations.
Scope:
The
standard operating procedure (SOP)
applicability for the clinical trials of the medical devices is decided on the
bases of CE marking. Standard Operating Procedures for Good Clinical Practice
has organized into eight sections:
• General
Administration: This section gives the outline of the infrastructure of the
activities of the clinical research program.
• Regulatory
Affairs: This section tells about the rules and regulations according to
FDA and this will also tell about the supplements, reports, and submissions
that are required to send to the FDA.
• Clinical
Protocol: It includes all the required approval, other
related documents as well as a review for protocol development.
• Study
Startup: This step includes the
selection for the investigative for the initiation of the study at different
research sites.
• Project
Management: This step describes the processes that help to manage the
clinical investigation that includes required documentation study and
investigation product management.
•
Subject Management: To the
protection of the research subjects there is a need for procedures that are
provided by subject management.
• Data
Management: This handles and manages the
collection of data after sites study and the use of EDC or Electronic Data
Capture systems for clinical investigation.
•
Quality Assurance: It provides
procedures for conducting internal audits, auditing investigative sites, managing
an FDA
inspection and assisting a Clinical Investigator in preparing for an FDA
inspection.
No comments:
Post a Comment